Acadia Pharmaceuticals Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $317.2M | $749.0M | $188.7M |
| FY2024 | $455.0M | $1.19B | $319.6M |
| FY2025 | $336.8M | $1.56B | $177.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2023 | $317.2M | $749.0M | $188.7M |
| FY2024 | $455.0M | $1.19B | $319.6M |
| FY2025 | $336.8M | $1.56B | $177.7M |